Coronary vascular function in patients with resistant hypertension and normal myocardial perfusion: a propensity score analysis.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
01 Aug 2019
Historique:
received: 21 11 2018
accepted: 30 01 2019
pubmed: 16 2 2019
medline: 3 11 2020
entrez: 16 2 2019
Statut: ppublish

Résumé

Impaired myocardial perfusion reserve (MPR) may occur earlier than coronary atherosclerosis and it may be an early manifestation of developing coronary artery disease (CAD) in patients with resistant hypertension (RH). We evaluated the relationship between RH and MPR in patients with systemic arterial hypertension after balancing for coronary risk factors. We studied 360 subjects without overt CAD and normal myocardial perfusion at stress-rest 82Rb positron emission tomography/computed tomography. To account for differences in baseline characteristics between patients with resistant and controlled hypertension, we created a propensity score-matched cohort considering clinical variables and coronary risk factors. Before matching, patients with RH were significantly older, had higher prevalence of male gender and hypercholesterolaemia, and showed significantly lower global hyperaemic myocardial blood flow (MBF) and MPR compared with those with controlled hypertension, while baseline MBF and coronary artery calcium (CAC) content were similar in both groups. After matching, there were no significant differences in clinical variables and coronary risk factors between patients with resistant and controlled hypertension, but patients with RH still had lower hyperaemic MBF and MPR (both P < 0.001). At univariable and multivariable linear regression analyses, age, RH, and CAC resulted significant predictors of lower MPR values (all P < 0.05). After balancing clinical characteristic by propensity score analysis, patients with RH had a blunted hyperaemic MBF and MPR compared with patients with controlled hypertension. The identification of impaired MPR could help to identify early structural alterations of the arterial walls in patients with RH.

Identifiants

pubmed: 30768182
pii: 5320318
doi: 10.1093/ehjci/jez025
doi:

Substances chimiques

Radiopharmaceuticals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

949-958

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Valeria Gaudieri (V)

Institute of Biostructure and Bioimaging, National Council of Research, Via De Amicis 95, Naples, Italy.

Wanda Acampa (W)

Institute of Biostructure and Bioimaging, National Council of Research, Via De Amicis 95, Naples, Italy.
Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, Naples, Italy.

Francesco Rozza (F)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, Naples, Italy.

Carmela Nappi (C)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, Naples, Italy.

Emilia Zampella (E)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, Naples, Italy.

Roberta Assante (R)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, Naples, Italy.

Teresa Mannarino (T)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, Naples, Italy.

Ciro Mainolfi (C)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, Naples, Italy.

Mario Petretta (M)

Department of Translational Medical Sciences, University Federico II, Via Pansini 5, Naples, Italy.

Hein J Verberne (HJ)

Department of Nuclear Medicine, Academic Medical Center University of Amsterdam, Meibergdreef 9, AZ, Amsterdam, The Netherlands.

Parthiban Arumugam (P)

Department of Nuclear Medicine, Central Manchester Foundation Trust, Manchester, UK.

Alberto Cuocolo (A)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH